✦ LIBER ✦

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer

✍ Scribed by Markus Büchler; Helmut Friess; Karl-Heinz Schultheiss; Christoph Gebhardt; Robert Kübel; Karl-Heinz Muhrer; Martin Winkelmann; Theo Wagener; Rainer Klapdor; Martin Kaul; Günther Müller; Gregor Schulz; Hans G. Beger

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 513 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19911001)68:7<1507::aid-cncr2820680707>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life after adjuvant intra-art

Quality of life after adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer : A prospective randomized controlled study

✍ Marjolein J. M. Morak; Chulja J. Pek; Erwin J. O. Kompanje; Wim C. J. Hop; Geert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

A randomized phase II trial of adjuvant

A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer

✍ Hideyuki Yoshitomi; Akira Togawa; Fumio Kimura; Hiroshi Ito; Hiroaki Shimizu; Hi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Infectious complications of monoclonal a

Infectious complications of monoclonal antibodies used in cancer therapy : A systematic review of the evidence from randomized controlled trials

✍ Petros I. Rafailidis; Ourania K. Kakisi; Konstantinos Vardakas; Matthew E. Falag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract The introduction of monoclonal antibodies (MoAbs) into the treatment of cancer has led to improvements in patient survival. However, to the authors' knowledge, little attention has been paid to the infectious complications associated with their use. The authors performed a systematic re